Avalyn Pharma Inc. (AVLN)
NASDAQ: AVLN · Real-Time Price · USD
29.76
-0.52 (-1.72%)
Nov 16, 2026, 4:00 PM EST - Market closed

Avalyn Pharma Statistics

Total Valuation

Avalyn Pharma has a market cap or net worth of $1.32 billion. The enterprise value is $955.29 million.

Market Cap1.32B
Enterprise Value 955.29M

Important Dates

The last earnings date was Thursday, November 12, 2026, before market open.

Earnings Date Nov 12, 2026
Ex-Dividend Date n/a

Share Statistics

Avalyn Pharma has 44.52 million shares outstanding. The number of shares has increased by 7,020.43% in one year.

Current Share Class 44.52M
Shares Outstanding 44.52M
Shares Change (YoY) +7,020.43%
Shares Change (QoQ) +49.59%
Owned by Insiders (%) n/a
Owned by Institutions (%) 73.32%
Float 29.88M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 3.57
P/TBV Ratio 3.58
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 25.76, with a Debt / Equity ratio of 0.05.

Current Ratio 25.76
Quick Ratio 25.40
Debt / Equity 0.05
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -182.30

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) -30.48%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee n/a
Profits Per Employee -$1.99M
Employee Count55
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 28.51
200-Day Moving Average n/a
Relative Strength Index (RSI) 57.23
Average Volume (20 Days) 502,001

Short Selling Information

The latest short interest is 2.30 million, so 5.17% of the outstanding shares have been sold short.

Short Interest 2.30M
Short Previous Month 2.35M
Short % of Shares Out 5.17%
Short % of Float 7.70%
Short Ratio (days to cover) 5.74

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -117.77M
Pretax Income -109.39M
Net Income -109.39M
EBITDA -117.48M
EBIT -117.77M
Earnings Per Share (EPS) -$5.69
Full Income Statement

Balance Sheet

The company has $386.60 million in cash and investments and $16.93 million in debt, with a net cash position of $369.67 million or $8.30 per share.

Cash & Investments 386.60M
Total Debt 16.93M
Net Cash 369.67M
Net Cash Per Share $8.30
Equity (Book Value) 370.25M
Book Value Per Share 8.34
Working Capital 320.75M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$106.44 million and capital expenditures -$911,000, giving a free cash flow of -$107.35 million.

Operating Cash Flow -106.44M
Capital Expenditures -911,000
Depreciation & Amortization 291,000
Net Borrowing 15.00M
Free Cash Flow -107.35M
FCF Per Share -$2.41
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Avalyn Pharma does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -7,020.43%
Shareholder Yield -7,020.43%
Earnings Yield -19.11%
FCF Yield -8.10%

Analyst Forecast

The average price target for Avalyn Pharma is $61.00, which is 104.97% higher than the current price. The consensus rating is "Strong Buy".

Price Target $61.00
Price Target Difference 104.97%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2